Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioHuman is a Brazilian biotechnology company specializing in regenerative medicine and tissue engineering. Based in the Supera Innovation and Technology Park in Ribeirão Preto, the company develops advanced biosynthetic skin substitutes and biological dressings for the treatment of complex wounds, such as chronic ulcers and severe burns. Its flagship technology, BioSkin, is a biosynthetic cellulose-based membrane that mimics the properties of human skin to promote accelerated healing and provide a protective barrier. BioHuman's products are designed to reduce patient pain and improve clinical outcomes in wound management. The company is a spin-off from research conducted at the University of São Paulo (USP).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioHuman.